Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Berchuck

Showing results (161-170 of 373) with videos related to

Pageof 38
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancersAndrew Berchuck, Joellen M Schildkraut, Robert M Wenham, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 19, 2013
Evidence of a chemopreventive effect of progestin unrelated to ovulation on reproductive tract cancers in the egg-laying henGustavo C Rodriguez, H John Barnes, Kenneth E Anderson, et al.
JNCI Cancer Spectrum|February 16, 2023
Health-care access dimensions and ovarian cancer survival: SEER-Medicare analysis of the ORCHiD studyMary Katherine Montes de Oca, Quan Chen, Elizabeth Howell, et al.
Communications Biology|June 2, 2022
Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancersBen Horst, Shrikant Pradhan, Roohi Chaudhary, et al.
Research Square|September 18, 2025
Vaginal Microbiome Composition, Diversity and Dysbiosis: The ORCHiD StudyApril Deveaux, Oyomoare Osazuwa-Peters, Yeon Ji Kim, et al.
Frontiers in Oncology|July 8, 2014
Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell LinesBrittany Anne Davidson, Jennifer M Rubatt, David L Corcoran, et al.
Molecular Cancer Research : MCR|February 12, 2009
Yin yang 1 modulates taxane response in epithelial ovarian cancerNoriomi Matsumura, Zhiqing Huang, Tsukasa Baba, et al.
Gynecologic Oncology|May 8, 2026
Estrogen hormone therapy use in ovarian cancer patients under age 60 at diagnosisAlexandra Lukey, Ali Salmanpour, Paramdeep Kaur, et al.
Communications Medicine|July 10, 2026
Characterizing the composition and diversity of the vaginal microbiome in ovarian cancerApril Deveaux, Oyomoare L Osazuwa-Peters, Yeon Ji Kim, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 27, 2022
Associations of Healthcare Affordability, Availability, and Accessibility with Quality Treatment Metrics in Patients with Ovarian CancerTomi F Akinyemiju, Lauren E Wilson, Nicole Diaz, et al.
Pageof 38

Showing results (161-170 of 373) with videos related to

Sort By:
Pageof 38
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancersAndrew Berchuck, Joellen M Schildkraut, Robert M Wenham, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 19, 2013
Evidence of a chemopreventive effect of progestin unrelated to ovulation on reproductive tract cancers in the egg-laying henGustavo C Rodriguez, H John Barnes, Kenneth E Anderson, et al.
JNCI Cancer Spectrum|February 16, 2023
Health-care access dimensions and ovarian cancer survival: SEER-Medicare analysis of the ORCHiD studyMary Katherine Montes de Oca, Quan Chen, Elizabeth Howell, et al.
Communications Biology|June 2, 2022
Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancersBen Horst, Shrikant Pradhan, Roohi Chaudhary, et al.
Research Square|September 18, 2025
Vaginal Microbiome Composition, Diversity and Dysbiosis: The ORCHiD StudyApril Deveaux, Oyomoare Osazuwa-Peters, Yeon Ji Kim, et al.
Frontiers in Oncology|July 8, 2014
Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell LinesBrittany Anne Davidson, Jennifer M Rubatt, David L Corcoran, et al.
Molecular Cancer Research : MCR|February 12, 2009
Yin yang 1 modulates taxane response in epithelial ovarian cancerNoriomi Matsumura, Zhiqing Huang, Tsukasa Baba, et al.
Gynecologic Oncology|May 8, 2026
Estrogen hormone therapy use in ovarian cancer patients under age 60 at diagnosisAlexandra Lukey, Ali Salmanpour, Paramdeep Kaur, et al.
Communications Medicine|July 10, 2026
Characterizing the composition and diversity of the vaginal microbiome in ovarian cancerApril Deveaux, Oyomoare L Osazuwa-Peters, Yeon Ji Kim, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 27, 2022
Associations of Healthcare Affordability, Availability, and Accessibility with Quality Treatment Metrics in Patients with Ovarian CancerTomi F Akinyemiju, Lauren E Wilson, Nicole Diaz, et al.
Pageof 38